3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
32
Neoplasms
26
Depression
21
Fatigue
20
Prostatic Neoplasms
13
Lymphoma, Follicular
12
Precursor Cell Lymphoblastic Leukemia-Lymphoma
11
Multiple Myeloma
11
Lymphoma, Large B-Cell, Diffuse
10
Lung Neoplasms
10
Colorectal Neoplasms
10
Carcinoma, Non-Small-Cell Lung
10
Pain
9
Lymphoma, Non-Hodgkin
9
Lymphoma, Mantle-Cell
9
Lymphoma, Large-Cell, Immunoblastic
9
Lymphoma, B-Cell, Marginal Zone
9
Leukemia, Myeloid, Chronic-Phase
9
Leukemia, Lymphocytic, Chronic, B-Cell
9
Hodgkin Disease
9
Burkitt Lymphoma
9
Anxiety Disorders
9
Vomiting
7
Nausea
7
Leukemia, Myeloid, Acute
7
Leukemia, Myeloid, Accelerated Phase
7
Leukemia, Hairy Cell
7
Head and Neck Neoplasms
7
Carcinoma, Ovarian Epithelial
7
Blast Crisis
7
Interventions
estradiol, norethindrone drug combination
9
asoprisnil
9
Uterine Myomectomy
9
telapristone acetate
8
Uterine Artery Embolization
8
ulipristal acetate
7
relugolix
7
elagolix
7
Estradiol
7
vilaprisan
5
Norethindrone Acetate
5
Mifepristone
5
ulipristal
4
linzagolix
4
Leuprolide
4
Tranexamic Acid
3
Sodium Chloride
3
Hysterectomy
3
Gonadotropin-Releasing Hormone
3
Embolization, Therapeutic
3
cetrorelix
2
Saline Solution
2
Radiofrequency Ablation
2
Progestins
2
Lidocaine
2
Letrozole
2
Goserelin
2
Endometrial Ablation Techniques
2
Anesthesia, General
2
pirfenidone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Leiomyoma
×
Therapeutics
×
Clear all
NCT04272216
2025-09-09
RAVI Registry
Terumo Medical Corporation
Completed
99 enrolled
15 charts